Literature DB >> 3227047

Classification of angiotensin receptors in rat isolated uterus, portal vein, and aorta with the novel competitive antagonist sarmesin.

M N Scanlon1, G J Moore.   

Abstract

Blockade of in vitro contractile responses to angiotensins II and III by the reversible competitive angiotensin antagonist [Sar1, Tyr(Me)4]ANG II (sarmesin) was investigated in 3 rat smooth muscle tissues. The pA2 values for sarmesin were: rat uterus, 7.46 +/- 0.04 versus ANG II and 7.46 +/- 0.07 versus ANG III; rat aorta, 7.98 +/- 0.07 versus ANG II and 7.67 +/- 0.08 versus ANG III; rat portal vein, 7.75 +/- 0.05 versus ANG II and 7.41 +/- 0.08 versus ANG III. Statistical analysis revealed that the pA2 values in each tissue were not significantly different, suggesting that ANG II and ANG III interact with the same receptors in each tissue. This conclusion was supported by cross-tachyphylaxis studies. Further statistical analysis revealed that pA2 values were not significantly different between tissues, suggesting that there are no readily discernible differences between angiotensin receptors in the 3 smooth muscle preparations investigated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3227047     DOI: 10.1159/000138457

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  3 in total

1.  Characterization of the angiotensin II-receptor subtype in the longitudinal smooth muscle of the rat portal vein.

Authors:  J S Zhang; J C Van Meel; M Pfaffendorf; P A Van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

2.  Pharmacological characterization of angiotensin-induced depolarizations of rat superior cervical ganglion in vitro.

Authors:  A B Hawcock; J C Barnes; A D Michel
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

3.  Inhibitory effect of dithiothreitol on angiotensin II-induced contractions mediated by AT1-receptors in rat portal vein and rabbit aorta.

Authors:  J S Zhang; J C van Meel; M Pfaffendorf; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-05       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.